CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial.
作者:
Jay Y,Spiegel [1]
;
Shabnum,Patel [2]
;
Lori,Muffly [1]
;
Nasheed M,Hossain [2]
;
Jean,Oak [3]
;
John H,Baird [4]
;
Matthew J,Frank [1]
;
Parveen,Shiraz [1]
;
Bita,Sahaf [1]
;
Juliana,Craig [2]
;
Maria,Iglesias [1]
;
Sheren,Younes [1]
;
Yasodha,Natkunam [4]
;
Michael G,Ozawa [4]
;
Eric,Yang [4]
;
John,Tamaresis [4]
;
Harshini,Chinnasamy [5]
;
Zach,Ehlinger [2]
;
Warren,Reynolds [2]
;
Rachel,Lynn [2]
;
Maria Caterina,Rotiroti [2]
;
Nikolaos,Gkitsas [6]
;
Sally,Arai [7]
;
Laura,Johnston [2]
;
Robert,Lowsky [1]
;
Robbie G,Majzner [1]
;
Everett,Meyer [1]
;
Robert S,Negrin [2]
;
Andrew R,Rezvani [7]
;
Surbhi,Sidana [1]
;
Judith,Shizuru [1]
;
Wen-Kai,Weng [1]
;
Chelsea,Mullins [1]
;
Allison,Jacob [1]
;
Ilan,Kirsch [1]
;
Magali,Bazzano [8]
;
Jing,Zhou [8]
;
Sean,Mackay [8]
;
Scott J,Bornheimer [9]
;
Liora,Schultz [9]
;
Sneha,Ramakrishna [9]
;
Kara L,Davis [10]
;
Katherine A,Kong [2]
;
Nirali N,Shah [7]
;
Haiying,Qin [11]
;
Terry,Fry [2]
;
Steven,Feldman [7]
;
Crystal L,Mackall [2]
;
David B,Miklos [7]
作者单位:
Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA.
[1]
Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.
[2]
Division of Hematology/Oncology, Loyola University Medical Center, Chicago, IL, USA.
[3]
Department of Clinical Pathology, Stanford University School of Medicine, Stanford, CA, USA.
[4]
Department of Biomedical Data Science, Stanford University School of Medicine, Stanford, CA, USA.
[5]
Lyell Immunopharma, San Francisco, CA, USA.
[6]
Department of Pediatrics-Hematology/Oncology, Stanford University School of Medicine, Stanford, CA, USA.
[7]
Adaptive Biotechnologies, Seattle, WA, USA.
[8]
IsoPlexis, Brantford, CT, USA.
[9]
BD Biosciences, San Jose, CA, USA.
[10]
Pediatric Oncology Branch Center for Cancer Research, National Institutes of Health, Bethesda, MD, USA.
[11]
Department of Pediatrics-Hematology/Oncology, University of Colorado Anschutz and Children's Hospital Colorado, Denver, CO, USA.
[12]
Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA. cmackall@stanford.edu.
[13]
Department of Pediatrics-Hematology/Oncology, Stanford University School of Medicine, Stanford, CA, USA. cmackall@stanford.edu.
[14]
Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA. dmiklos@stanford.edu.
[15]
Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA. dmiklos@stanford.edu.
[16]
主题词
成年人(Adult);老年人(Aged);抗原, CD19(Antigens, CD19);疾病恶化(Disease Progression);人类(Humans);免疫疗法, 过继(Immunotherapy, Adoptive);淋巴瘤, B细胞(Lymphoma, B-Cell);中年人(Middle Aged);复发(Recurrence)
DOI
10.1038/s41591-021-01436-0
PMID
34312556
发布时间
2024-06-15
- 浏览3

Nature medicine
Nature medicine
1419-1431页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文